INDV-6001 Multiple-Dose Pharmacokinetic Study
NCT06576843
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
123
Enrollment
INDUSTRY
Sponsor class
Conditions
Moderate to Severe Opioid Use Disorder
Interventions
DRUG:
INDV-6001
DRUG:
Suboxone
DRUG:
Sublocade
Sponsor
Indivior Inc.